Get started
Author

J.J.W.M. Janssen

Observed names: J J W M Janssen, J. Janssen, J.J.W.M., Janssen, JJWM Janssen, Janssen, J. J., Janssen, J.J.W.M., Janssen, JJWM
OpenAlex ID: A5049105261
New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure.
2011 · N Thielen, G J Ossenkoppele, et al. · PubMed · 17
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies
2007 · G.J. Timmers, A.M. Simoons-Smit, et al. · Clinical Microbiology and Infection · 16
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
2020 · Rüdiger Hehlmann, Astghik Voskanyan, et al. · Leukemia · 6
PDF
Final Donor Versus No Donor Comparison of Newly Diagnosed Myeloma Patientes Included in the Hovon 50/54 Study
2010 · Lokhorst, H., Sonneveld, P., et al. · Pure Amsterdam UMC · 4
Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient.
2003 · M E D Chamuleau, W Deenik, et al. · PubMed · 3
Empirische antibiotische therapie voor koorts bij neutropenie in Nederland
2018 · de la Court, JR, Janssen, JJWM, et al. · Pure Amsterdam UMC · 2
PKP-014 Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood samples
2014 · AM Schimmel, CCLM Boons, et al. · European Journal of Hospital Pharmacy · 1
Guidelines Acute promyelocyten leukemia (APL):guidelines for diagnosis and treatment
2018 · Huls, G.A., Löwenberg, Bob; id_orcid 0000-0001-8982-5217, et al. · EUR Research Repository (Erasmus University Rotterdam)
Specific Targeting of Acute Myeloid Leukemia Stem Cells by Insulin-like Growth Factor Binding Protein 7
2017 · Verhagen, H. J., van Gils, N., et al. · Pure Amsterdam UMC
Hemato-oncologie
2017 · Zweegman, S, Kater, A.P., et al. · Pure Amsterdam UMC
Hoge dosis imatinib versus hoge dosis imatinib in combinatie met intermediaire dosis cytarabine bij patiënten met nieuw gediagnosticeerde chronische myeloïde leukemie: een gerandomiseerde fase III-studie van de Stichting HematoOncologie voor Volwassenen Nederland (HOVON)
2014 · Thielen, N., van der Holt, B., et al. · Pure Amsterdam UMC
Chronische myeloïde leukemie en therapietrouw
2014 · Thielen, N., Boons, C.C.L.M., et al. · Pure Amsterdam UMC
Hematologie
2014 · Zweegman, S., van der Horst, H.E., et al. · Pure Amsterdam UMC
Prognostic value of CIP2A level for response to nilotinib in CML patients after failure or intolerance of imatinib
2013 · G.J. Ossenkoppele, J.J.W.M. Janssen
Predictive value of stem cell enumeration for the response to nilotinib in newly diagnosed CML patients
2013 · Cornelis van Kuijk, G. J. Ossenkoppele, et al.
Phosphoproteomics for personalized treatment of acute myeloid leukemia with kinase inhibitors
2013 · Jacqueline Cloos, J.J.W.M. Janssen, et al.
PHAROS project: Nationwide registration of clinical and outcome data of CML in the Netherlands
2013 · J.J.W.M. Janssen, G.J. Ossenkoppele, et al.
Prediction of achievement of deep molecular responses to combination treatment with nilotinib and pegylated interferon-alpha in chronic myeloid leukemia
2013 · J.J.W.M. Janssen, Gerrit‐Jan Schuurhuis, et al.
Reduced-intensity conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation : a study by the European Group for Blood and Marrow Transplantation Chronic Malignancies Working Party
2013 · Holger W. Auner, Richard Szydlo, et al. · Bone Marrow Transplantation
Therapeutic Drug Monitoring van tyrosinekinaseremmers bij chronische myeloide leukemie. Noodzaak of nodeloos?
2013 · Wilhelm, A.J., van Erp, N.P., et al. · Pure Amsterdam UMC
Hematologie
2013 · Zweegman, S., van der Horst, H.E., et al. · Pure Amsterdam UMC
Characterization of the leukemic stem cell compartment in chronic myeloid leukemia (CML)
2012 · J.J.W.M. Janssen, G.J. Ossenkoppele
Discontinuation of imatinib in CML patients in continuous complete molecular remission
2011 · J.J.W.M. Janssen, G. J. Ossenkoppele
Hematologie
2011 · Zweegman, S., van der Horst, H.E., et al. · Pure Amsterdam UMC
Psy33 Early Stage Economic Evaluation of Pharmacogenomicbased Diagnostics in Chronic Myeloid Leukemia
2010 · J Gaultney, E Sanhueza, et al. · Value in Health
PDF
Works count: 34
Citation count: 49
H-index: 4
I10-index: 2
Year
Topic
Type